Cortisol does not live alone. It sits at a metabolic crossroads where three regulatory axes — HPA (adrenal), HPT (thyroid), and HPG (gonadal) — share substrate, share signaling, and crash together. You can run the most precise sleep and cortisol reset in the world and watch it stall at week 4 if the downstream thyroid is sluggish, the upstream sex-hormone cascade is being robbed, or the conversion enzymes are starved of cofactors. This chapter is the audit of what's flowing alongside cortisol — and the targeted layer-ins to clear the bottlenecks.
What's actually happening — three axes, one substrate pool
Every steroid hormone in your body traces back to a single precursor: cholesterol. Cholesterol becomes pregnenolone. Pregnenolone then branches — one arm heads toward DHEA, testosterone, estrogen, and progesterone; the other arm heads toward cortisol. Under chronic stress, the body shunts pregnenolone into the cortisol arm preferentially. This is the pregnenolone steal, and it is one of the most consistent patterns in practitioner-tier endocrine work: elevated cortisol parallels depleted DHEA, suppressed testosterone, and suppressed progesterone in women. Cortisol "wins" the substrate competition because acute survival outranks reproduction and tissue repair.
The thyroid layer is the next compression point. Your hypothalamus signals the pituitary to release TSH, which tells the thyroid gland to produce mostly T4 (the inactive storage form). T4 must be converted into T3 — the active hormone your cells actually use — by the deiodinase enzyme family, which is selenium-dependent. Elevated cortisol downregulates this conversion. So does iron deficiency. So does a low-calorie diet. So do pro-inflammatory cytokines. The result is a pattern the corpus describes repeatedly: TSH that looks normal-ish, T4 that looks normal-ish, but T3 sitting in the lower third of the range and reverse T3 climbing. Your thyroid gland is making the hormone. Your body is failing to activate it. Symptomatically, this looks like the cortisol-recovery patient who got their morning cortisol back to range, sleep improved, but energy and body temperature still feel flat.
The HPG axis closes the loop. Gonadotropin-releasing hormone (GnRH) pulses from the hypothalamus drive LH and FSH, which drive testosterone in men and the estrogen-progesterone cycle in women. Chronic cortisol elevation flattens GnRH pulsatility. The kisspeptin neuron — the upstream master switch that activates GnRH — is described in the practitioner corpus as "the bouncer of your entire reproductive axis," and it is exquisitely sensitive to systemic stress, leptin signaling, and inflammation. When you reset cortisol but leave the kisspeptin-GnRH layer suppressed, recovery testosterone production lags by months. Women with HPA dysfunction get Hashimoto's at higher rates than men — the axes are not parallel, they are entangled.
Reading the labs that actually matter here
Cortisol/DHEA ratio is the workhorse marker. The corpus describes this as the cleanest single readout of HPA load. Salivary cortisol at 9pm should be approximately 1; "a lot of people are four, six, eight" — high enough to blunt overnight repair without being acutely pathological. Pair this with DHEA-sulfate (DHEA-S) to see whether the cortisol elevation is robbing the anabolic arm.
Free T3 and reverse T3 together are the conversion check. TSH alone is insufficient. The corpus describes patients whose pituitary signaling looks intact but who are "getting converted into excess amounts of reverse T3 rather than T3." The fix isn't more TSH. The fix is removing the conversion blockers — cortisol, low iron, undereating, inflammation — and in some cases supplementing T3 directly.
Testosterone (total + free) in men, and progesterone (luteal phase) in women, complete the picture. Testosterone production rises with sleep duration up to ten hours, then declines — the cortisol reset feeds testosterone recovery as a downstream effect. Progesterone in the luteal phase is what determines whether a perimenopausal woman sleeps through the night or wakes at 3am with surging heat.
Protocol prescription — supporting compounds for weeks 5-10
This stack layers onto the cortisol reset from Chapter 4. The intent is not aggressive replacement — it is unblocking the conversion and re-pulsing the suppressed upstream signals.
| Compound | Dose | Route | Frequency | Evidence Tier | Notes |
|---|---|---|---|---|---|
| Pregnenolone | [practitioner corpus thin on specific dose — track and report] | Oral | Morning | 🟢 Expert | Restores the substrate pool upstream of the steal. Anchor the day, not the night. |
| DHEA | [practitioner corpus thin on specific dose — track and report] | Oral | Morning | 🟢 Expert | Run only if DHEA-S is in lower quartile. Re-test at week 8. |
| Progesterone (women, luteal phase) | Oral, dose per practitioner protocol | Oral | Nightly during luteal phase | 🟢 Expert | The corpus describes oral progesterone at night as the "valium that bathes the female mind" — GABAergic, sedating, sleep-restorative. |
| T3 (liothyronine / Cytomel) | Practitioner-dosed by free T3 / reverse T3 | Oral | Morning, sometimes split | 🔵 Clinical | Skip the middleman when conversion is blocked. Re-test at week 6. |
| Kisspeptin-10 | 50–100 mcg | SubQ | Daily | 🟣 Experimental | Upstream GnRH stimulator. Maintains HPG axis pulsatility during HPA recovery. |
| Gonadorelin | [practitioner corpus thin on specific dose for this indication — track and report] | SubQ | Per practitioner protocol | 🟢 Expert | Direct GnRH analog. Sustains LH/FSH pulse when kisspeptin layer is the suspected bottleneck. |
| Selenium | 200 mcg | Oral | Daily | 🔵 Clinical | Deiodinase cofactor. The conversion enzyme literally cannot function without it. |
| Iron (if ferritin < 70) | Per labs | Oral | Daily | 🔵 Clinical | Iron deficiency directly impairs T4→T3 conversion. Don't skip the ferritin check. |
What's NOT happening yet
- You are not "rebalancing your hormones." You are removing the blockers and re-pulsing the suppressed signals. Replacement at this stage is bridge therapy, not destination therapy.
- Pregnenolone and DHEA are not a stack you run forever. They are run while the pregnenolone steal pattern is active. When morning cortisol normalizes and DHEA-S climbs into mid-range on its own, you taper.
- T3 supplementation is not the answer if conversion blockers remain. Cortisol still elevated, ferritin still under 70, selenium still depleted — adding T3 chases the symptom while the upstream pattern persists.
- Kisspeptin-10 is not a TRT alternative for hypogonadal men. It is an axis-maintenance compound. If endogenous testosterone is suppressed by a primary testicular issue rather than upstream HPA load, kisspeptin will not rescue it.
- Progesterone is not estrogen replacement. Women in early perimenopause with disrupted sleep but regular cycling — that is the substrate-described use case. Full HRT is a different conversation.
The practitioner corpus describes these axes as one integrated system. Track the ratios, not the isolated numbers, and adjust.